These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9454907)
1. Fas (APO-1/CD95)-mediated apoptosis is independent of bcl-2: a study with cell lines overexpressing bcl-2 and with bcl-2 transfected cell lines. Gazitt Y; Hu WX Int J Oncol; 1998 Jan; 12(1):211-20. PubMed ID: 9454907 [TBL] [Abstract][Full Text] [Related]
3. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. Weller M; Malipiero U; Aguzzi A; Reed JC; Fontana A J Clin Invest; 1995 Jun; 95(6):2633-43. PubMed ID: 7539458 [TBL] [Abstract][Full Text] [Related]
4. G-protein signaling abnormalities mediated by CD95 in salivary epithelial cells. Liu XB; Masago R; Kong L; Zhang BX; Masago S; Vela-Roch N; Katz MS; Yeh CK; Zhang GH; Talal N; Dang H Cell Death Differ; 2000 Nov; 7(11):1119-26. PubMed ID: 11139286 [TBL] [Abstract][Full Text] [Related]
5. Modulation of Apo-1/Fas (CD95)-induced programmed cell death in myeloma cells by interferon-alpha 2. Egle A; Villunger A; Kos M; Böck G; Gruber J; Auer B; Greil R Eur J Immunol; 1996 Dec; 26(12):3119-26. PubMed ID: 8977313 [TBL] [Abstract][Full Text] [Related]
6. Apoptotic behaviour of hepatic and extra-hepatic tumor cell lines differs after Fas stimulation. Lamboley C; Bringuier AF; Feldmann G Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):13-28. PubMed ID: 10726968 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis. Chetoui N; Sylla K; Gagnon-Houde JV; Alcaide-Loridan C; Charron D; Al-Daccak R; Aoudjit F Mol Cancer Res; 2008 Jan; 6(1):42-52. PubMed ID: 18234961 [TBL] [Abstract][Full Text] [Related]
8. Sensitivity of S49.1 cells to anti-CD95 (Fas/Apo-1)-induced apoptosis: effects of CD95, Bcl-2 or Bcl-x transduction. Broome HE; Dargan CM; Brunner T; Green DR Cell Death Differ; 1998 Mar; 5(3):200-5. PubMed ID: 10200465 [TBL] [Abstract][Full Text] [Related]
9. The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver. Terradillos O; de La Coste A; Pollicino T; Neuveut C; Sitterlin D; Lecoeur H; Gougeon ML; Kahn A; Buendia MA Oncogene; 2002 Jan; 21(3):377-86. PubMed ID: 11821950 [TBL] [Abstract][Full Text] [Related]
10. BCL-X expression in multiple myeloma: possible indicator of chemoresistance. Tu Y; Renner S; Xu F; Fleishman A; Taylor J; Weisz J; Vescio R; Rettig M; Berenson J; Krajewski S; Reed JC; Lichtenstein A Cancer Res; 1998 Jan; 58(2):256-62. PubMed ID: 9443402 [TBL] [Abstract][Full Text] [Related]
11. Dexamethasone induces apoptosis in human T cell clones expressing low levels of Bcl-2. Gilardini Montani MS; Tuosto L; Giliberti R; Stefanini L; Cundari E; Piccolella E Cell Death Differ; 1999 Jan; 6(1):79-86. PubMed ID: 10200551 [TBL] [Abstract][Full Text] [Related]
12. Resistance to Fas-mediated apoptosis of human T-cell lines expressing human T-lymphotropic virus type-2 (HTLV-2) Tax protein. Zehender G; Varchetta S; De Maddalena C; Colasante C; Riva A; Meroni L; Moroni M; Galli M Virology; 2001 Mar; 281(1):43-50. PubMed ID: 11222094 [TBL] [Abstract][Full Text] [Related]
13. Apoptosis-induced by TRAIL AND TNF-alpha in human multiple myeloma cells is not blocked by BCL-2. Gazitt Y; Shaughnessy P; Montgomery W Cytokine; 1999 Dec; 11(12):1010-9. PubMed ID: 10623426 [TBL] [Abstract][Full Text] [Related]
14. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas. Cerrato JA; Khan T; Koul D; Lang FF; Conrad CA; Yung WK; Liu TJ Int J Oncol; 2004 Feb; 24(2):409-17. PubMed ID: 14719118 [TBL] [Abstract][Full Text] [Related]
15. All-trans retinoic acid modulates Fas antigen expression and affects cell proliferation and apoptosis in combination with anti-Fas monoclonal antibody in the human myeloma cell line, U266B1. Okamura T; Masuda M; Arai Y; Ishida C; Shudou K; Mizoguchi H Exp Hematol; 1998 Jun; 26(6):501-6. PubMed ID: 9620283 [TBL] [Abstract][Full Text] [Related]
16. Ceramide-induced apoptosis in fas-resistant Hodgkin's disease cell lines is caspase independent. Metkar SS; Anand M; Manna PP; Naresh KN; Nadkarni JJ Exp Cell Res; 2000 Feb; 255(1):18-29. PubMed ID: 10666330 [TBL] [Abstract][Full Text] [Related]
18. Apoptosis gene expression and death receptor signaling in mitomycin-C-treated human tenon capsule fibroblasts. Crowston JG; Chang LH; Constable PH; Daniels JT; Akbar AN; Khaw PT Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):692-9. PubMed ID: 11867586 [TBL] [Abstract][Full Text] [Related]
19. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma. Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844 [TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin. Geller J; Petak I; Szucs KS; Nagy K; Tillman DM; Houghton JA Clin Cancer Res; 2003 Dec; 9(17):6504-15. PubMed ID: 14695155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]